Background: Adverse cardiovascular events are a leading cause of perioperative morbidity and mortality. The definitions of perioperative cardiovascular adverse events are heterogeneous. As part of the international Standardized Endpoints in Perioperative Medicine initiative, this study aimed to find consensus amongst clinical trialists on a set of standardised and valid cardiovascular outcomes for use in future perioperative clinical trials. Methods: We identified currently used perioperative cardiovascular outcomes by a systematic review of the anaesthesia and perioperative medicine literature (PubMed/Ovid, Embase, and Cochrane Library). We performed a three-stage Delphi consensus-gaining process that involved 55 clinician researchers worldwide. Cardiovascular outcomes were first shortlisted and the most suitable definitions determined. These cardiovascular outcomes were then assessed for validity, reliability, feasibility, and clarity. Results: We identified 18 cardiovascular outcomes. Participation in the three Delphi rounds was 100% (n=19), 71% (n=55), and 89% (n=17), respectively. A final list of nine cardiovascular outcomes was elicited from the consensus: myocardial infarction, myocardial injury, cardiovascular death, non-fatal cardiac arrest, coronary revascularisation, major adverse cardiac events, pulmonary embolism, deep vein thrombosis, and atrial fibrillation. These nine cardiovascular outcomes were rated by the majority of experts as valid, reliable, feasible, and clearly defined. Conclusions: These nine consensus cardiovascular outcomes can be confidently used as endpoints in clinical trials designed to evaluate perioperative interventions with the goal of improving perioperative outcomes.

Systematic review and consensus definitions for the Standardized Endpoints in Perioperative Medicine (StEP) initiative: cardiovascular outcomes

Landoni G.;Pelosi P.;Cabrini L.;
2021-01-01

Abstract

Background: Adverse cardiovascular events are a leading cause of perioperative morbidity and mortality. The definitions of perioperative cardiovascular adverse events are heterogeneous. As part of the international Standardized Endpoints in Perioperative Medicine initiative, this study aimed to find consensus amongst clinical trialists on a set of standardised and valid cardiovascular outcomes for use in future perioperative clinical trials. Methods: We identified currently used perioperative cardiovascular outcomes by a systematic review of the anaesthesia and perioperative medicine literature (PubMed/Ovid, Embase, and Cochrane Library). We performed a three-stage Delphi consensus-gaining process that involved 55 clinician researchers worldwide. Cardiovascular outcomes were first shortlisted and the most suitable definitions determined. These cardiovascular outcomes were then assessed for validity, reliability, feasibility, and clarity. Results: We identified 18 cardiovascular outcomes. Participation in the three Delphi rounds was 100% (n=19), 71% (n=55), and 89% (n=17), respectively. A final list of nine cardiovascular outcomes was elicited from the consensus: myocardial infarction, myocardial injury, cardiovascular death, non-fatal cardiac arrest, coronary revascularisation, major adverse cardiac events, pulmonary embolism, deep vein thrombosis, and atrial fibrillation. These nine cardiovascular outcomes were rated by the majority of experts as valid, reliable, feasible, and clearly defined. Conclusions: These nine consensus cardiovascular outcomes can be confidently used as endpoints in clinical trials designed to evaluate perioperative interventions with the goal of improving perioperative outcomes.
2021
2020
cardiovascular events; clinical trials; MACE; myocardial infarction; outcome measures; perioperative medicine; standardised endpoint; Cardiovascular Diseases; Clinical Trials as Topic; Consensus; Delphi Technique; Endpoint Determination; Humans; Perioperative Care; Perioperative Medicine; Postoperative Complications; Research Design
Beattie, W. S.; Lalu, M.; Bocock, M.; Feng, S.; Wijeysundera, D. N.; Nagele, P.; Fleisher, L. A.; Kurz, A.; Biccard, B.; Leslie, K.; Howell, S.; Landoni, G.; Grocott, H.; Lamy, A.; Richards, T.; Myles, P.; Gan, T. J.; Peyton, P.; Sessler, D.; Tramer, M.; Cyna, A.; De Oliveira, G. S.; Wu, C.; Jensen, M.; Kehlet, H.; Botti, M.; Boney, O.; Haller, G.; Grocott, M.; Cook, T.; Fleisher, L.; Neuman, M.; Story, D.; Gruen, R.; Bampoe, S.; Evered, L.; Scott, D.; Silbert, B.; van Dijk, D.; Kalkman, C.; Chan, M.; Eckenhoff, R.; Rasmussen, L.; Eriksson, L.; Landoni, G.; Bartlett, R. J.; Mcmonnies, R.; Gerstl, J.; Jay, M.; Kishlyansky, D.; Machina, M.; Bobcock, M.; Pearse, R.; Mythen, M.; Canet, J.; Moller, A.; Gin, T.; Schultz, M.; Pelosi, P.; Gabreu, M.; Futier, E.; Creagh-Brown, B.; Abbott, T.; Klein, A.; Corcoran, T.; Cooper, D. J.; Dieleman, S.; Diouf, E.; Mcilroy, D.; Bellomo, R.; Shaw, A.; Prowle, J.; Karkouti, K.; Billings, J.; Mazer, D.; Jayarajah, M.; Murphy, M.; Bartoszko, J.; Sneyd, R.; Morris, S.; George, R.; Moonesinghe, R.; Shulman, M.; Lane-Fall, M.; Nilsson, U.; Stevenson, N.; Cooper, J. D.; van Klei, W.; Cabrini, L.; Miller, T.; Pace, N.; Jackson, S.; Buggy, D.; Short, T.; Riedel, B.; Gottumukkala, V.; Alkhaffaf, B.; Johnson, M.
File in questo prodotto:
File Dimensione Formato  
perioperative endpoints BJA 2021.pdf

non disponibili

Tipologia: Versione Editoriale (PDF)
Licenza: DRM non definito
Dimensione 195.53 kB
Formato Adobe PDF
195.53 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11383/2122979
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 45
social impact